OREX Related Analyst Ratings
-
Rodman & Renshaw Initiates Coverage on Orexigen Therapeutics (OREX) with a Market Outperform
-
Canaccord Adds Orexigen Therapeutics (OREX) to Best Ideas List; $21 PT
-
Leerink Swann Starts Orexigen Therapeutics (OREX) at Outperform
-
J.P. Morgan Assumes Coverage on Orexigen (OREX) with an Overweight
-
ThinkEquity Starts Orexigen Therapeutics (OREX) at Accumulate
-
Merrill Lynch Starts Orexigen Therapeutics (OREX) at Buy
-
JP Morgan Starts Orexigen (OREX) at Overweight
-
JMP Securities Initiates Coverage on Orexigan (OREX) with a Market Outperform
-
Leerink Swann Starts Orexigen Therapeutics (OREX) at Outperform
Back to OREX Stock Lookup
